BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25640641)

  • 21. Role of cannabinoid receptors in hepatic fibrosis and apoptosis associated with bile duct ligation in rats.
    Mahmoud MF; Swefy SE; Hasan RA; Ibrahim A
    Eur J Pharmacol; 2014 Nov; 742():118-24. PubMed ID: 25179573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CB2 cannabinoid receptor agonist, JWH-015, triggers apoptosis in immune cells: potential role for CB2-selective ligands as immunosuppressive agents.
    Lombard C; Nagarkatti M; Nagarkatti P
    Clin Immunol; 2007 Mar; 122(3):259-70. PubMed ID: 17185040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cannabinoid CB2 receptor-specific agonist AM1241 increases pentylenetetrazole-induced seizure severity in Wistar rats.
    de Carvalho CR; Hoeller AA; Franco PL; Martini AP; Soares FM; Lin K; Prediger RD; Whalley BJ; Walz R
    Epilepsy Res; 2016 Nov; 127():160-167. PubMed ID: 27608434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potency.
    Smoum R; Baraghithy S; Chourasia M; Breuer A; Mussai N; Attar-Namdar M; Kogan NM; Raphael B; Bolognini D; Cascio MG; Marini P; Pertwee RG; Shurki A; Mechoulam R; Bab I
    Proc Natl Acad Sci U S A; 2015 Jul; 112(28):8774-9. PubMed ID: 26124120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Δ
    Shang VC; Kendall DA; Roberts RE
    Biochem Pharmacol; 2016 Nov; 120():63-71. PubMed ID: 27641813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CB2 cannabinoid receptors promote mouse neural stem cell proliferation.
    Molina-Holgado F; Rubio-Araiz A; García-Ovejero D; Williams RJ; Moore JD; Arévalo-Martín A; Gómez-Torres O; Molina-Holgado E
    Eur J Neurosci; 2007 Feb; 25(3):629-34. PubMed ID: 17328768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabinoid receptors in conjunctival epithelium: identification and functional properties.
    Iribarne M; Torbidoni V; Julián K; Prestifilippo JP; Sinha D; Rettori V; Berra A; Suburo AM
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4535-44. PubMed ID: 18566465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel CB2 agonist, COR167, potently protects rat brain cortical slices against OGD and reperfusion injury.
    Contartese A; Valoti M; Corelli F; Pasquini S; Mugnaini C; Pessina F; Aldinucci C; Sgaragli G; Frosini M
    Pharmacol Res; 2012 Dec; 66(6):555-63. PubMed ID: 23036353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation.
    Palazuelos J; Aguado T; Egia A; Mechoulam R; Guzmán M; Galve-Roperh I
    FASEB J; 2006 Nov; 20(13):2405-7. PubMed ID: 17015409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Proliferative Properties and Proapoptotic Function of New CB2 Selective Cannabinoid Receptor Agonist in Jurkat Leukemia Cells.
    Capozzi A; Mattei V; Martellucci S; Manganelli V; Saccomanni G; Garofalo T; Sorice M; Manera C; Misasi R
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29973514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor.
    Klegeris A; Bissonnette CJ; McGeer PL
    Br J Pharmacol; 2003 Jun; 139(4):775-86. PubMed ID: 12813001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of ERK1/2, cPLA2 and NF-κB in microglia suppression by cannabinoid receptor agonists and antagonists.
    Ribeiro R; Wen J; Li S; Zhang Y
    Prostaglandins Other Lipid Mediat; 2013 Jan; 100-101():1-14. PubMed ID: 23219970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabinoid receptor agonists and antagonists stimulate insulin secretion from isolated human islets of Langerhans.
    Li C; Bowe JE; Huang GC; Amiel SA; Jones PM; Persaud SJ
    Diabetes Obes Metab; 2011 Oct; 13(10):903-10. PubMed ID: 21564460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system.
    Romero TR; Resende LC; Guzzo LS; Duarte ID
    Anesth Analg; 2013 Feb; 116(2):463-72. PubMed ID: 23302980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral cannabinoid receptor, CB2, regulates bone mass.
    Ofek O; Karsak M; Leclerc N; Fogel M; Frenkel B; Wright K; Tam J; Attar-Namdar M; Kram V; Shohami E; Mechoulam R; Zimmer A; Bab I
    Proc Natl Acad Sci U S A; 2006 Jan; 103(3):696-701. PubMed ID: 16407142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
    Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
    Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. JWH-133, a Selective Cannabinoid CB₂ Receptor Agonist, Exerts Toxic Effects on Neuroblastoma SH-SY5Y Cells.
    Wojcieszak J; Krzemień W; Zawilska JB
    J Mol Neurosci; 2016 Apr; 58(4):441-5. PubMed ID: 26842917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset.
    Shoemaker JL; Seely KA; Reed RL; Crow JP; Prather PL
    J Neurochem; 2007 Apr; 101(1):87-98. PubMed ID: 17241118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amidoalkylindoles as Potent and Selective Cannabinoid Type 2 Receptor Agonists with in Vivo Efficacy in a Mouse Model of Multiple Sclerosis.
    Shi Y; Duan YH; Ji YY; Wang ZL; Wu YR; Gunosewoyo H; Xie XY; Chen JZ; Yang F; Li J; Tang J; Xie X; Yu LF
    J Med Chem; 2017 Aug; 60(16):7067-7083. PubMed ID: 28726401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation.
    Caffarel MM; Sarrió D; Palacios J; Guzmán M; Sánchez C
    Cancer Res; 2006 Jul; 66(13):6615-21. PubMed ID: 16818634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.